Targeted lung denervation lowers COPD exacerbations, improves quality of life over 2 years

SAN DIEGO — Patients with COPD treated with targeted lung denervation along with optimal COPD therapy experienced fewer exacerbations over 2 years, according to research presented at the American Thoracic Society International Conference.Targeted lung denervation (Nuvaira Inc.) has “only [been] done in research setting to date,” Gerard J. Criner, MD, FACP, FACCP, chair and

Related Keywords

United States ,San Diego ,California ,American ,Kristen Dowd ,Gerardj Criner ,Byisabella Hornick ,Nuvaira Inc ,Temple Lung Center ,American Thoracic Society International Conference ,American Thoracic Society International ,Lewis Katz School ,Temple University ,